Ease and safety of insertion, contraceptive performance and effect on menstrual blood loss of a new LNG-IUS, Femilis™, in parous and nulliparous women

Ease and safety of insertion, contraceptive performance and

effect on menstrual blood loss of a new LNG-IUS, Femilis™, in parous and

nulliparous women

D. Wildemeersch

Contrel Research, Zwijnaarde, Ghent, Belgium

Objective To evaluate ease and safety of insertion,

contraceptive performance and effect on menstrual blood loss of a new LNG-IUS),

Femilis™, releasing 20 mg of LNG/day.

Design and methods An open, prospective non-comparative

study (interim analysis). Two- hundred and thirty-five insertions were performed

in fertile women seeking contraception, 143 (60.8%) parous and 92 (39.2%)

nulliparous women. The LNG-IUS was inserted using a simplified push-in technique.

In 60 women, MBL was assessed with the visual assessment technique after 4 to 30

months.

Results The push-in technique of insertion was considered

simple and safe. Insertion was reported ‘easy’ in virtually all women (97.9%).

No pregnancies were observed. There was one expulsion in the nulliparous and one

in the parous group. Ten removals were performed for medical reasons (mainly

bleeding and pain). One pelvic infection occurred which resolved without

removing the IUS. Femilis was well tolerated which resulted in a high

continuation rate (94.04%). An update of the study will be given during the

congress. MBL scores dropped significantly during the observation period in all

women except one. Twenty women developed amenorrhea (33%). Most of the remaining

women had oligomenorrhea requiring the use of a few panty-liners only.

Conclusion The Femilis LNG-IUS is an effective

contraceptive and is easily inserted. The simple and safe insertion procedure

could be an advantage for use by non-specialist providers such as nurses,

midwives, general practitioners, and for those not inserting intrauterine

devices regularly. The strong effect on MBL of this contraceptive method offers

an important health benefit and improvement in quality of life, particularly in

women with heavy bleeding and anemia, as other treatment modalities are less

effective, more costly, more invasive or not readily available.

Scroll to Top